FHD43412
Human
Human
IgG1, kappa
Monoclonal
PE
Myelin-associated glycoprotein, MAG, Siglec-4a, GMA
0.5 mg/ml
Please contact with the lab for this information.
ELISA, FCM
Liquid
0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.
Store at 4°C for 12 months. Protect from light. Do not freeze.
SAA0779
Clinical and Electrodiagnostic Findings in Anti-myelin-Associated Glycoprotein Antibody Polyneuropathy: A Single Center Review., PMID:40513035
Clinical and Electrodiagnostic Findings in Anti-myelin-Associated Glycoprotein Antibody Polyneuropathy: A Single Center Review., PMID:40513035
Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies., PMID:40507880
Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies., PMID:40507880
Nerve ultrasound in the diagnosis of inflammatory neuropathies., PMID:40501305
Nerve ultrasound in the diagnosis of inflammatory neuropathies., PMID:40501305
[Diffuse large B-cell lymphoma presenting with anti-MAG/SGPG IgM gammopathy and neurolymphomatosis at onset]., PMID:40467458
[Diffuse large B-cell lymphoma presenting with anti-MAG/SGPG IgM gammopathy and neurolymphomatosis at onset]., PMID:40467458
Severe Worsening of Neuropathy Associated With Antibodies Against Myelin-Associated Glycoprotein by Rituximab Resembling Chronic Inflammatory Demyelinating Polyneuropathy., PMID:40452709
Severe Worsening of Neuropathy Associated With Antibodies Against Myelin-Associated Glycoprotein by Rituximab Resembling Chronic Inflammatory Demyelinating Polyneuropathy., PMID:40452709
Secreted EMC10 inhibits muscle GLUT4 activity and glucose uptake in mice., PMID:40441535
Secreted EMC10 inhibits muscle GLUT4 activity and glucose uptake in mice., PMID:40441535
Coexistence of anti-MOG and anti-MAG antibodies in combined central and peripheral nervous system demyelination: a case of dual myelinopathy., PMID:40418511
Coexistence of anti-MOG and anti-MAG antibodies in combined central and peripheral nervous system demyelination: a case of dual myelinopathy., PMID:40418511
Treatment of Anti-Myelin-Associated Glycoprotein (MAG) Antibody Neuropathy Using Zanubrutinib in a Patient With Waldenström Macroglobulinemia: A Clinical Vignette., PMID:40351903
Treatment of Anti-Myelin-Associated Glycoprotein (MAG) Antibody Neuropathy Using Zanubrutinib in a Patient With Waldenström Macroglobulinemia: A Clinical Vignette., PMID:40351903
Treatment of Anti-Myelin-Associated Glycoprotein Neuropathy with Tirabrutinib and a 3-Year Follow-Up: A Case Report., PMID:40301028
Treatment of Anti-Myelin-Associated Glycoprotein Neuropathy with Tirabrutinib and a 3-Year Follow-Up: A Case Report., PMID:40301028
[Rapidly progressive muscle weakness in anti-myelin associated glycoprotein (MAG) neuropathy successfully treated with intravenous immunoglobulin]., PMID:40139810
[Rapidly progressive muscle weakness in anti-myelin associated glycoprotein (MAG) neuropathy successfully treated with intravenous immunoglobulin]., PMID:40139810
Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adults., PMID:40119067
Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adults., PMID:40119067
Acute kidney injury, coagulopathy, and deep vein thrombosis following a haemotoxic snakebite: A case report from a resource-limited setting., PMID:40118158
Acute kidney injury, coagulopathy, and deep vein thrombosis following a haemotoxic snakebite: A case report from a resource-limited setting., PMID:40118158
Acute onset anti-MAG neuropathy and paradoxical worsening to rituximab: a challenging case., PMID:40053180
Acute onset anti-MAG neuropathy and paradoxical worsening to rituximab: a challenging case., PMID:40053180
Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review., PMID:39852808
Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review., PMID:39852808
The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysis., PMID:39814271
The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysis., PMID:39814271
Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial., PMID:39794302
Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial., PMID:39794302
Learning the language of antibody hypervariability., PMID:39793083
Learning the language of antibody hypervariability., PMID:39793083
[Diseases Separated from Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Anti-Myelin-Associated Glycoprotein Neuropathy and Autoimmune Nodopathy]., PMID:39725755
[Diseases Separated from Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Anti-Myelin-Associated Glycoprotein Neuropathy and Autoimmune Nodopathy]., PMID:39725755
Neuropathy with anti-myelin-associated glycoprotein antibodies: update on diagnosis, pathophysiology and management., PMID:39658134
Neuropathy with anti-myelin-associated glycoprotein antibodies: update on diagnosis, pathophysiology and management., PMID:39658134
Do specific myelin autoantibodies and increased cerebral dopamine neurotrophic factor in the context of inflammation predict the diagnosis of attention deficit hyperactivity disorder in medication-free children?, PMID:39617068
Do specific myelin autoantibodies and increased cerebral dopamine neurotrophic factor in the context of inflammation predict the diagnosis of attention deficit hyperactivity disorder in medication-free children?, PMID:39617068
The Role of Complement Activation in IgM M-Protein-Associated Neuropathies., PMID:39571136
The Role of Complement Activation in IgM M-Protein-Associated Neuropathies., PMID:39571136
Complement activation by IgM autoantibodies linked to immune-mediated neuropathies depends on C2., PMID:39545641
Complement activation by IgM autoantibodies linked to immune-mediated neuropathies depends on C2., PMID:39545641
IgA Vasculitis (Henoch-Schönlein Purpura): An Update on Treatment., PMID:39518760
IgA Vasculitis (Henoch-Schönlein Purpura): An Update on Treatment., PMID:39518760
Monoclonal Gammopathy in Patients with Neuropathy., PMID:39506578
Monoclonal Gammopathy in Patients with Neuropathy., PMID:39506578
Optimizing Anti-Myelin-Associated Glycoprotein and IgM-Gammopathy Testing for Neuropathy Treatment Evaluation., PMID:39499873
Optimizing Anti-Myelin-Associated Glycoprotein and IgM-Gammopathy Testing for Neuropathy Treatment Evaluation., PMID:39499873
Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments., PMID:39399552
Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments., PMID:39399552
Primary neurolymphomatosis with MAG antibody: a case report., PMID:39237863
Primary neurolymphomatosis with MAG antibody: a case report., PMID:39237863
PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients., PMID:39203959
PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients., PMID:39203959
Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers., PMID:39156689
Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers., PMID:39156689
Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test., PMID:39088795
Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test., PMID:39088795
Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine., PMID:39080316
Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine., PMID:39080316
Molecular imaging for non-invasive risk stratification of renal masses., PMID:39054210
Molecular imaging for non-invasive risk stratification of renal masses., PMID:39054210
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma., PMID:39043638
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma., PMID:39043638
Uncommon Presentation of IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Anti-Myelin-Associated Glycoprotein (MAG)-Associated Demyelinating Peripheral Neuropathy as Respiratory Failure: A Case Report., PMID:38912071
Uncommon Presentation of IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Anti-Myelin-Associated Glycoprotein (MAG)-Associated Demyelinating Peripheral Neuropathy as Respiratory Failure: A Case Report., PMID:38912071
Tell-tale immune-related neurological syndromes: Should we look for and underlying low-grade B-cell lymphoma? A retrospective study on 12 cases., PMID:38850875
Tell-tale immune-related neurological syndromes: Should we look for and underlying low-grade B-cell lymphoma? A retrospective study on 12 cases., PMID:38850875
Paraproteinemic neuropathies., PMID:38816958
Paraproteinemic neuropathies., PMID:38816958
Enhancing the sequence coverage of nanodiamond-extracted early secretory proteins from the Mycobacterium tuberculosis complex., PMID:38804556
Enhancing the sequence coverage of nanodiamond-extracted early secretory proteins from the Mycobacterium tuberculosis complex., PMID:38804556
[Anti-Myelin-associated Glycoprotein Neuropathy]., PMID:38741494
[Anti-Myelin-associated Glycoprotein Neuropathy]., PMID:38741494
[Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021]., PMID:38644208
[Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021]., PMID:38644208
Time course of the autoantibody response to therapy in anti-MAG neuropathy: TWO case REPORTS., PMID:38601656
Time course of the autoantibody response to therapy in anti-MAG neuropathy: TWO case REPORTS., PMID:38601656
EMC10 modulates hepatic ER stress and steatosis in an isoform-specific manner., PMID:38599383
EMC10 modulates hepatic ER stress and steatosis in an isoform-specific manner., PMID:38599383
Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis., PMID:38578496
Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis., PMID:38578496
Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases., PMID:38529039
Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases., PMID:38529039
Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders., PMID:38494281
Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders., PMID:38494281
Consequences of COVID-19 on Adipose Tissue Signatures., PMID:38474155
Consequences of COVID-19 on Adipose Tissue Signatures., PMID:38474155
Typical CIDP, distal variant CIDP, and anti-MAG antibody neuropathy: An ultra-high frequency ultrasound comparison of nerve structure., PMID:38409319
Typical CIDP, distal variant CIDP, and anti-MAG antibody neuropathy: An ultra-high frequency ultrasound comparison of nerve structure., PMID:38409319
Prevalence and clinical profiles of anti-myelin-associated glycoprotein neuropathy in Japan: A nationwide survey study of 133 patients., PMID:38375741
Prevalence and clinical profiles of anti-myelin-associated glycoprotein neuropathy in Japan: A nationwide survey study of 133 patients., PMID:38375741
Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials., PMID:38325389
Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials., PMID:38325389
Mode of progression in smoldering multiple myeloma: a study of 406 patients., PMID:38228628
Mode of progression in smoldering multiple myeloma: a study of 406 patients., PMID:38228628
Upper and lower limb tremor in inflammatory neuropathies., PMID:38194761
Upper and lower limb tremor in inflammatory neuropathies., PMID:38194761
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
